VRNA Verona Pharma: Nilai bisnis marang pendapatan

Logo perusahaan publik Verona Pharma PLC (VRNA)

Verona Pharma plc (VRNA) is implementing advanced respiratory therapy methods, creating unique drug classes. Stable demand for such medications minimizes the impact of economic crises, while strict control over raw material supplies eliminates logistical disruptions. This chart in the GURU.Markets terminal illustrates the EV/Sales history, where the value has settled at , signaling a potential overheating of the asset's valuation relative to revenue.

veronapharma.com (VRNA): Rasio nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Verona Pharma Corp (VRNA)

- rega lan prakiraan konsensus rega:
Analisis wiwitan perusahaan:Verona Pharma plc
Produk seri Verona Pharma PLC

Institutional capital utilizes this metric to determine asset overbought conditions through the lens of its actual market value. The EV-to-revenue ratio for the company compares the total enterprise value, adjusted for net debt, against sales volume to reveal capitalization efficiency. For Verona Pharma plc (VRNA), this indicator reflects market expectations regarding the implementation of eco-friendly inhalers, confirming the fundamental resilience of the biopharmaceutical business.

Analisis pesaing Verona Pharma plc

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amneal Pharmaceuticals Inc AMRX|Multiplikator EV/Sales PRGO|Koefisien nilai perusahaan marang pendapatan ALVO|Multiplikator EV/Sales LQDA (Liquidia Technologies)|Multiplikator EV/Sales Galapagos GLPG|ANI Pharmaceuticals Inc - Multiplikator EV/Sales|MNKD (MannKind Corp.) - Rasio nilai perusahaan marang pendapatan|AMPH: Multiplikator EV/Sales|PCRX (Pacira BioSciences) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ARS Pharmaceuticals Inc|Nilai perusahaan marang pendapatan Theravance Biopharma, Inc. (TBPH)|Nilai perusahaan marang pendapatan AQST (Aquestive Pharma)|SCPH - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales TECX (Tectonic Therapeutic, Inc.)|TNXP - Nilai perusahaan marang pendapatan|China SXT Pharmaceuticals, Inc. - Multiplikator EV/Sales|EPRX - Multiplikator EV/Sales|BHST: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan ENTX (Entera Bio)|Rasio nilai perusahaan marang pendapatan MindWalk (HYFT)|Multiplikator EV/Sales ABVC BioPharma, Inc. (ABVC)|Rasio nilai perusahaan marang pendapatan Cumberland Corp CPIX|QNTM - Nilai perusahaan marang pendapatan|FGEN - Rasio nilai perusahaan marang pendapatan|TELO - Multiplikator EV/Sales|Rani Therapeutics Inc (RANI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNYR|Rasio nilai perusahaan marang pendapatan Rallybio Corp|Rasio nilai perusahaan marang pendapatan LEXX|Multiplikator EV/Sales PULM|PTHL: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales APM (Aptorum Group Ltd)|LYRA - Nilai perusahaan marang pendapatan|Impact BioMedical Inc - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan TNFA|YCBD (cbdmd.com) - Nilai perusahaan marang pendapatan|painreform.com - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan CYTO|Rasio nilai perusahaan marang pendapatan LIPO|Rasio nilai perusahaan marang pendapatan optinose.com (OPTN)|PIRS (Pieris Pharma) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Procaps Group S.A. PROC|Rasio total nilai perusahaan marang pendapatan petrospharma.com (PTPI)|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan